Private investments in insurance are on pace to end the year with their highest total in more than a decade.
Used as an escape hatch when private equity is in the doldrums, this venue has become established enough to keep going in better days, strategists say.
U.S. venture fund returns remain negative, but valuations are up and two recent high-profile VC-supported IPOs did well, a PitchBook report finds.
As it stands, shareholders must assent to M&A or related-party deals. But the FCA wants to ease listing requirements to stem companies decamping to New York exchanges.
Lower valuations and lots of unspent cash are the ingredients for an eventual upturn, says PitchBook.
Sponsors invested in deals worth $740 million during the quarter, down from nearly $14 billion in Q1.
The proposed disclosure rules in the White House’s antitrust push could make filing for deals more difficult, critics argue.
The buyout firms are increasingly popular among institutional investors—Carlyle just raised $27 billion.
